Stocks in play: Cameco Corp.
Today reported its consolidated financial and operating results for the fourth quarter ended December 31, 2022 in accordance with International Financial Reporting Standards (IFRS). Fourth-quarter net loss of $15 million; adjusted net earnings of $36 million. Fourth-quarter results are driven by normal quarterly variations in contract deliveries and the continued execution of our strategy. Annual net earnings of $89 million; adjusted net earnings of $135 million. Cameco Corp. shares T.CCO are trading up $1.79 at $38.55.
Read:
The Future of Lithium in Nevada: Companies Pour in Money, with Expansions Underway
Addressing the USA’s 200 to 1 Security Protection Gap is a Serious Concern for Tech Companies
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer